The AIDS epidemic has focused attention on the constraints and deficiencies present in many blood transfusion services in the developing world. We discuss a variety of options for reducing transfusion-related HIV transmission, and suggest how new transfusion strategies may be implemented. We show that a transfusion service cannot rely solely on the screening of donor blood for anti-HIV antibodies and that a more comprehensive approach is needed. Important components of this approach include donor selection and improved clinical practice, in which blood and blood products are prescribed only when really necessary.
Get full access to this article
View all access options for this article.
References
1.
Centers for Disease Control. Update on acquired immune deficiency syndrome (AIDS) among patients with haemophilia A. Morbid Mortal Weekly Rep1982; 31: 644
2.
Centers for Disease Control. Possible transfusion-associated acquired immune deficiency syndrome (AIDS) — California. Morbid Mortal Weekly Rep1982; 31: 652
3.
Centers for Disease Control. Unexplained immunodeficiency and opportunistic infections in infants — New York, New Jersey, California. Morbid Mortal Weekly Rep1982; 31: 665
4.
Centers for Disease Control. Prevention of acquired immune deficiency syndrome (AIDS): report of inter-agency recommendations. Morbid Mortal Weekly Rep1983; 32: 101
5.
NkurunzizaJStouffsLSondag-ThullD. Transfusion in Rwanda. IVth International Conference on AIDS and associated cancers in Africa, Marseille, 18–20 October, 1989
6.
AubuchonJPDoddRY. Analysis of the relative safety of autologous blood units available for transfusion to homologous recipients. Transfusion1988; 28: 403–5
7.
StarkeyJMMacPhersonJLBolgranoDC, Markers for transfusion-transmitted disease in different groups of blood donors. JAMA1989; 262: 3452–4
8.
WardJWHolmbergSDAllenJRCohnDL, Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. N Engl J Med1988; 318: 473–8
9.
ImagawaDTLeeMHWolinskySMSanoK, Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med1989; 320: 1458–62
10.
WolinskyS, Polymerase Chain Reaction (PCR). Detection of HIV Provirus before HIV Seroconversion, IVth International Conference on AIDS, Stockholm, 12–16 June 1988
11.
Van de PerrePLepagePBatungwanayoJBonnetD. Adult and paediatric AIDS patients lacking HIV antibodies detected by enzyme immunoassay in central Africa: further serological studies. AIDS, 1989; 3: 429–31
12.
GodyMOuattaraSAde TheG. Clinical experience of AIDS in relation to HIV-1 and HIV-2 infections in a rural hospital in Ivory Coast, West Africa. AIDS1988; 2: 433–6
13.
Global Blood Safety Initiative. Minimum targets for blood transfusion services, WHO/GPA/INF/89.14, 1989
14.
International Dispensary Association, Price Indicator, October 1989
15.
MaulerRMerkleWHilfenhausJ. Inactivation of HTLV-III/LAV, hepatitis B and non-A non-B viruses by pasteurisation in human protein preparations. Dev Biol Stand1987; 67: 337–51
16.
StephanW. Inactivation of hepatitis viruses and HIV in plasma derivatives by treatment with b-proprionolactone UV irradiation. In: Morgenthaler JJ, Current studies in hematology and blood transfusion, No 56, Virus inactivation in plasma products. Basel: Karger, 1989: 122–7
17.
League of Red Cross Societies. Manual for Investigators and Project Directors, Geneva, 1983
